What You Need to Know About Raynaud’s Phenomenon

Recent Posts

• Large study IDs risks for primary heart involvement in scleroderma
• Age, sex, socioeconomics tied to localized scleroderma risk: Study
• Why those of us with scleroderma need patient-centered care
• Sex differences confirmed in SSc, with 5 times higher risk for women
• Exosome-based therapy eases skin scarring in scleroderma mice: Study
• ALLO-329 gets FDA fast track designation for diffuse scleroderma
• Finding the ‘Goldilocks zone’ to manage scleroderma, Raynaud’s
• Study of CAR T-cell therapy rese-cel in scleroderma enrolling in US
• Ofev effectiveness, safety seen over 3-year SENSCIS extension trial
• Phase 1 trial of CAR T-cell therapy likely to open soon to SSc patients